Skip to main content
Premium Trial:

Request an Annual Quote

Microchip Biotechnologies Licenses Sample Loading System Tech from UC Berkeley

NEW YORK (GenomeWeb News) — Microchip Biotechnologies said today that it has licensed a patent and its related applications from the University of California, Berkeley.
According to MBI, the privately held firm has obtained an exclusive license for US Patent No. 6,623,613, "Microfabricated Liquid Sample Loading System" and related patent applications developed by UC Berkeley Professor Richard Mathies and his team.
Stevan Jovanovich, president and CEO of MBI, called the IP “foundational to MBI's ongoing development of a … nanofluidics platform for the construction of integrated devices."
Microchip Biotechnologies develops nanofluidic sample preparation and analytical instrumentation for the genomics and biodefense markets.
Last week, the company announced that it had raised $4.5 million in a Series A funding round.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.